Department of Pediatric, Daping Hospital, Army Medical University, China; Department of Pediatric, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China.
Department of Plastic Surgery, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China.
Brain Res Bull. 2024 Nov;218:111101. doi: 10.1016/j.brainresbull.2024.111101. Epub 2024 Oct 11.
Brain injury often results in high mortality rates and significant sequelae following severe heatstroke (HS). Neuroinflammation aggravates HS-induced brain injury, yet the involvement of microglia in heat-induced neuroinflammation deserves further investigation.
Our study investigated activation status, phenotype markers, production of pro-inflammatory cytokine and reactive oxygen species (ROS) of microglia both in vitro and in vivo under HS. Utilizing high-throughput sequencing, we identified SIRT1 as a potential modulator of microglia phenotype, and observed that SIRT1 alleviated severe heatstroke-induced brain injury following intraperitoneal administration of the SIRT1 agonist SRT-1720 and the inhibitor selisistat. Additionally, the effects of SRT-1720 and selisistat on mitochondrial dynamics and microglial phenotype transition were examined in BV2 cells in vitro.
Heatstroke promotes microglia activation, as evidenced by the increased production of pro-inflammatory cytokine and reactive oxygen species. High-throughput sequencing revealed elevated expression of SIRT1 in BV2 cells under HS. Upon inhibition of SIRT1 expression, there was a corresponding increase in pro-inflammatory cytokine, iNOS, and ROS expression in BV2 cells. In vivo experiments with the SIRT1 agonist SRT-1720 showed a mitigation of neuron injury under HS, as assessed by Nissl and HE staining. Activation of SIRT1 was associated with a reduction in mitochondrial injury and a decrease in the phosphorylation of mitochondrial fission protein Drp1. Furthermore, the heat-induced activation of microglia was reversed by the Drp1 inhibitor, Mdivi.
Our findings provided evidence that SIRT1 played a crucial role in inhibiting heat stress-induced microglial activation. By suppressing the phosphorylation of mitochondrial fission protein Drp1, SIRT1 contributed to the reduction of neuroinflammation and severity of heatstroke-induced brain injury.
脑损伤常导致严重中暑(HS)后死亡率高和明显后遗症。神经炎症加重 HS 引起的脑损伤,但小胶质细胞在热诱导神经炎症中的作用值得进一步研究。
我们的研究在体外和体内研究了 HS 下小胶质细胞的激活状态、表型标志物、促炎细胞因子和活性氧(ROS)的产生。利用高通量测序,我们确定 SIRT1 是小胶质细胞表型的潜在调节剂,观察到 SIRT1 经腹腔给予 SIRT1 激动剂 SRT-1720 和抑制剂 selisistat 后减轻严重中暑引起的脑损伤。此外,还研究了 SRT-1720 和 selisistat 对体外 BV2 细胞中线粒体动力学和小胶质细胞表型转换的影响。
HS 促进小胶质细胞激活,表现为促炎细胞因子和活性氧产生增加。高通量测序显示 HS 下 BV2 细胞中 SIRT1 表达升高。抑制 SIRT1 表达后,BV2 细胞中促炎细胞因子、iNOS 和 ROS 的表达相应增加。体内实验用 SIRT1 激动剂 SRT-1720 显示 HS 下神经元损伤减轻,Nissl 和 HE 染色评估。SIRT1 的激活与线粒体损伤减少和线粒体分裂蛋白 Drp1 磷酸化减少有关。此外,Drp1 抑制剂 Mdivi 逆转了热诱导的小胶质细胞激活。
我们的研究结果表明,SIRT1 在抑制热应激诱导的小胶质细胞激活中起关键作用。通过抑制线粒体分裂蛋白 Drp1 的磷酸化,SIRT1 有助于减少神经炎症和减轻中暑引起的脑损伤的严重程度。